Basal ganglia accumulation and motor assessment following manganese chloride exposure in the C57BL/6 mouse

International Journal of Toxicology

Volumn 24, Issue 6, 2005, Pages 389-397

  Dodd, Celia A ^a   Ward, Daniel L ^a   Klein, Bradley G ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

Basal Ganglia; C57BL 6 Mouse; Manganese Neurotoxicity; Motor Behavior; Parkinson's Disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; MANGANESE CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BIOACCUMULATION; BODY WEIGHT; BREEDING; CLINICAL FEATURE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; GRIP STRENGTH; INJECTION; LOCOMOTION; MALE; MEDICAL INFORMATION; MOUSE; MOUSE STRAIN; MUSCLE FATIGUE; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; REARING; RISK ASSESSMENT; SWIMMING;

ANALYSIS OF VARIANCE; ANIMALS; BASAL GANGLIA; BEHAVIOR, ANIMAL; CHLORIDES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; INJECTIONS, SUBCUTANEOUS; MALE; MANGANESE; MANGANESE COMPOUNDS; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PARKINSON DISEASE, SECONDARY;

ANIMALIA;

EID: 30344451956     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810500366500     Document Type: Article

References (64)

1. Aschner, M., K. M. Erikson, and D. C. Dorman. 2005. Manganese dosimetry: Species differences and implications for neurotoxicity. Crit. Rev. Toxicol. 35:1-32.
2. Aschner, M., K. E. Vrana, and W. Zheng. 1999. Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology 20:173-180.
3. Baek, S. Y., J. H. Cho, E. S. Kim, H. J. Kim, S. Yoon, B. S. Kim, J. B. Kim, C. R. Lee, C. Yoo, J. H. Lee, H. Lee, J. Park, J. W. Kim, and Y. Kim. 2004. CDNA array analysis of gene expression profiles in brain of mice exposed to manganese. Ind. Health 42:315-320.
4. Baek, S. Y., M. J. Lee, H. S. Jung, H. J. Kim, C. R. Lee, C. Yoo, J. H. Lee, H. Lee, C. S. Yoon, Y. H. Kim, J. Park, J. W. Kim, B. S. Jeon, and Y. Kim. 2003. Effect of manganese exposure on MPTP neurotoxicities. Neurotoxicology 24:657-665.
5. Bolam, J. P., J. J. Hanley, P. A. Booth, and M. D. Bevan. 2000. Synaptic organisation of the basal ganglia. J. Anat. 196(Pt 4):527-542.
6. Calne, D. B., N. S. Chu, C. C. Huang, C. S. Lu, and W. Olanow. 1994. Manganism and idiopathic parkinsonism: Similarities and differences. Neurology 44:1583-1586.
7. Canavan, M., S. Cobb, and C.K. Drinker. 1934. Chronic manganese poisoning: Report of a case with autopsy. Arch. Neurol. Psychiatry 32:501-512.
8. Crocker, S. J., P. D. Smith, V. Jackson-Lewis, W. R. Lamba, S. P. Hayley, E. Grimm, S. M. Callaghan, R. S. Slack, E. Melloni, S. Przedborski, G. S. Robertson, H. Anisman, Z. Merali, and D. S. Park. 2003. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J. Neurosci. 23:4081-4091.
9. Crossman, A. R. 2000. Functional anatomy of movement disorders. J. Anat. 196(Pt 4):519-525.
10. Dean, A. M., and D. T. Voss. 1999. Design and analysis of experiments. New York: Springer-Verlag.
11. Di Monte, D., and J. W. Langston. 1995. Idiopathic and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism. In Neuroglia, ed. H. Kettenmann and B. R. Ransom, 977-989. New York: Oxford University Press.
12. Dodd, C. A., and B. G. Klein. 2003. Interaction of the basal ganglia neurotoxicants manganese and MPTP in a mouse model of Parkinson's disease: Neurochemical and behavioral analyses. Soc. Neurosci. Absts. Program No. 410.17.
13. Donnan, G. A., G. L. Willis, S. J. Kaczmarczyk, and P. Rowe. 1987. Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. J. Neurol. Sci. 77:185-191.
14. Dorman, D. C., B. E. McManus, M. W. Marshall, R. A. James, and M. F. Struve. 2004a. Old age and gender influence the pharmacokinetics of inhaled manganese sulfate and manganese phosphate in rats. Toxicol. Appl. Pharmacol. 197:113-124.
15. Dorman, D. C., B. E. McManus, C. U. Parkinson, C. A. Manuel, A. M. McElveen, and J. I. Everitt. 2004b. Nasal toxicity of manganese sulfate and manganese phosphate in young male rats following subchronic (13-week) inhalation exposure. Inhal. Toxicol. 16:481-488.
16. Dorman, D. C., M. F. Struve, R. A. James, M. W. Marshall, C. U. Parkinson, and B. A. Wong. 2001. Influence of particle solubility on the delivery of inhaled manganese to the rat brain: Manganese sulfate and manganese tetroxide pharmacokinetics following repeated (14-day) exposure. Toxicol. Appl. Pharmacol. 170:79-87.
17. Fernagut, P. O., E. Diguet, B. Bioulac, and F. Tison. 2004. MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: Reference to striatonigral degeneration. Exp. Neurol. 185:47-62.
18. Gianutsos, G., M. D. Seltzer, R. Saymeh, M. L. Wu, and R. G. Michel. 1985. Brain manganese accumulation following systemic administration of different forms. Arch. Toxicol. 57:272-275.
19. Gillette, J. S., and J. R. Bloomquist. 2003. Differential up-regulation of striatal dopamine transporter and alpha-synuclein by the pyrethroid insecticide permethrin. Toxicol. Appl. Pharmacol. 192:287-293.
20. Giovanni, A., B. A. Sieber, R. E. Heikkila, and P. K. Sonsalla. 1991. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine administration to several strains of mice. J. Pharmacol. Exp. Ther. 257:691-697.
21. Gorell, J. M., C. C. Johnson, B. A. Rybicki, E. L. Peterson, G. X. Kortsha, G. G. Brown, and R. J. Richardson. 1997. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 48:650-658.
22. Gorell, J. M., C. C. Johnson, B. A. Rybicki, E. L. Peterson, G. X. Kortsha, G. G. Brown, and R. J. Richardson. 1999. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 20:239-247.
23. Gray, L., Jr. and J. W. Laskey. 1980. Multivariate analysis of the effects of manganese on the reproductive physiology and behavior of the male house mouse. J. Toxicol. Environ. Health 6:861-867.
24. Hayley, S., S. J. Crocker, P. D. Smith, T. Shree, V. Jackson-Lewis, S. Przedborski, M. Mount, R. Slack, H. Anisman, and D. S. Park. 2004. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J. Neurosci. 24:2045-2053.
25. Heikkila, R. E., F. S. Cabbat, L. Manzino, and R. C. Duvoisin. 1984. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice. Neuropharmacology 23:711-713.
26. Kaiser, J. 2003. Manganese: A high-octane dispute. Science 300:926-928.
27. Karen, D. J., W. Li, P. R. Harp, J. S. Gillette, and J. R. Bloomquis. 2001. Striatal dopaminergic pathways as a target for the insecticides permethrin and chlorpyrifos. Neurotoxicology 22:811-817.
28. Kim, S. H., K. H. Chang, J. G. Chi, H. K. Cheong, J. Y. Kim, Y. M. Kim, and M. H. Han. 1999. Sequential change of MR signal intensity of the brain after manganese administration in rabbits. Correlation with manganese concentration and histopathologic findings. Invest. Radiol. 34:383-393.
29. Kim, Y. 2004. High signal intensities on T1-weighted MRI as a biomarker of exposure to manganese. Ind. Health 42:111-115.
30. Klein, B. G., M. L. Kirby, E. R. Freeborn, and J. R. Bloomquist. 2001. Pharmacological properties of the MPTP analog trans-1-methyl-4-[4- dimethylaminophenylethenyl]-1,2,3,6-tetrahydropyridine and its pyridinium metabolite in mouse brain synaptosomes: A potential visual marker for substrates of MPTP-induced neurotoxicity. Prog. Neuropsychopharmacol. Biol. Psychiatry 25:591-608.
31. Komura, J., and M. Sakamoto. 1992. Effects of manganese forms on biogenic amines in the brain and behavioral alterations in the mouse: Long-term oral administration of several manganese compounds. Environ. Res. 57:34-44.
32. Lee, J. W. 2000. Manganese intoxication. Arch. Neurol. 57:597-599.
33. Markey, S. P., J. N. Johannessen, C. C. Chiueh, R. S. Burns, and M. A. Herkenham. 1984. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature 311:464-467.
34. Morganti, J. B., B. A. Lown, C. H. Stineman, R. B. D'Agostino, and E. J. Massaro. 1985. Uptake, distribution and behavioral effects of inhalation exposure to manganese (MnO2) in the adult mouse. Neurotoxicology 6:1-15.
35. Natt, O., T. Watanabe, S. Boretius, J. Radulovic, J. Frahm, and T. Michaelis. 2002. High-resolution 3D MRI of mouse brain reveals small cerebral structures in vivo. J. Neurosci. Methods 120:203-209.
36. Normandin, L., L. Ann Beaupre, F. Salehi, A. St-Pierre, G. Kennedy, D. Mergler, R. F. Butterworth, S. Philippe, and J. Zayed. 2004. Manganese distribution in the brain and neurobehavioral changes following inhalation exposure of rats to three chemical forms of manganese. Neurotoxicology 25:433-441.
37. Normandin, L., M. Panisset, and J. Zayed. 2002. Manganese neurotoxicity: Behavioral, pathological, and biochemical effects following various routes of exposure. Rev. Environ. Health 17:189-217.
38. Nwanze, E., F. Souverbie, G. Jonsson, and E. Sundstrom. 1995. Regional biotransformation of MPTP in the CNS of rodents and its relation to neurotoxicity. Neurotoxicology 16:469-477.
39. Olanow, C. W., P. F. Good, H. Shinotoh, K. A. Hewitt, F. Vingerhoets, B. J. Snow, M. F. Beal, D. B. Calne, and D. P. Perl. 1996. Manganese intoxication in the rhesus monkey: A clinical, imaging, pathologic, and biochemical study. Neurology 46:492-498.
40. Olanow, C. W., and W. G. Tatton. 1999. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22:123-144.
41. Pal, P. K., A. Samii, and D. B. Calne. 1999. Manganese neurotoxicity: A review of clinical features, imaging and pathology. Neurotoxicology 20:227-238.
42. Park, J., C. I. Yoo, C. S. Sim, H. K. Kim, J. W. Kim, B. S. Jeon, K. R. Kim, O. Y. Bang, W. Y. Lee, Y. Yi, K. Y. Jung, S. E. Chung, and Y. Kim. 2005. Occupations and Parkinson's disease: A multi-center case-control study in South Korea. Neurotoxicology 26:99-105.
43. Park, J., C. I. Yoo, C. S. Sim, J. W. Kim, Y. Yi, K. Y. Jung, S. E. Chung, and Y. Kim. 2004. Occupations and Parkinson's disease: A case-control study in South Korea. Ind. Health 42:352-358.
44. Racette, B. A., L. McGee-Minnich, S. M. Moerlein, J. W. Mink, T. O. Videen, and J. S. Perlmutter. 2001. Welding-related parkinsonism: Clinical features, treatment, and pathophysiology. Neurology 56:8-13.
45. 2) on the absorption and cerebral distribution of manganese in rats. Arch. Toxicol. 71:223-230.
46. Rojas, P., and C. Rios. 1995. Short-term manganese pretreatment partially protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Neurochem. Res. 20:1217-1223.
47. Royland, J. E., and J. W. Langston. 1998. MPTP: A dopaminergic neurotoxin. In Highly selective neurotoxins: Basic and clinical applications, ed. R. M. Kostrzewa, 141-194. Totowa: Humana Press.
48. Samii, A., J. G. Nutt, and B. R. Ransom. 2004. Parkinson's disease. Lancet 363:1783-1793.
49. Schmidt, N., and B. Ferger. 2001. Neurochemical findings in the MPTP model of Parkinson's disease. J. Neural. Transm. 108:1263-1282.
50. Sedelis, M., K. Hofele, G. W. Auburger, S. Morgan, J. P. Huston, and R. K. Schwarting. 2000. MPTP susceptibility in the mouse: Behavioral, neurochemical, and histological analysis of gender and strain differences. Behav. Genet. 30:171-182.
51. Seidler, A., W. Hellenbrand, B. P. Robra, P. Vieregge, P. Nischan, J. Joerg, W. H. Oertel, G. Ulm, and E. Schneider. 1996. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: A case-control study in Germany. Neurology 46:1275-1284.
52. Semchuk, K. M., E. J. Love, and R. G. Lee. 1993. Parkinson's disease: A test of the multifactorial etiologic hypothesis. Neurology 43:1173-1180.
53. Sotogaku, N., N. Oku, and A. Takeda. 2000. Manganese concentration in mouse brain after intravenous injection. J. Neurosci. Res. 61:350-356.
54. Spadoni, F., A. Stefani, M. Morello, F. Lavaroni, P. Giacomini, and G. Sancesario. 2000. Selective vulnerability of pallidal neurons in the early phases of manganese intoxication. Exp. Brain Res. 135:544-551.
55. Sziraki, I., K. P. Mohanakumar, P. Rauhala, H. G. Kim, K. J. Yeh, and C. C. Chiueh. 1998. Manganese: A transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of parkinsonism. Neuroscience 85:1101-1111.
56. Sziraki, I., P. Rauhala, and C. C. Chiueh. 1995. Novel protective effect of manganese against ferrous citrate-induced lipid peroxidation and nigrostriatal neurodegeneration in vivo. Brain Res. 698:285-287.
57. Takahashi, R. N., R. Rogerio, and M. Zanin. 1989. Maneb enhances MPTP neurotoxicity in mice. Res. Commun. Chem. Pathol. Pharmacol. 66:167-170.
58. Takeda, A. 2003. Manganese action in brain function. Brain Res. Brain Res. Rev. 41:79-87.
59. Takeda, A., J. Sawashita, and S. Okada. 1995. Biological half-lives of zinc and manganese in rat brain. Brain Res. 695:53-58.
60. Talavera, E. J., J. L. Arcaya, D. Giraldoth, J. Suarez, and E. Bonilla. 1999. Decrease in spontaneous motor activity and in brain lipid peroxidation in manganese and melatonin treated mice. Neurochem. Res. 24:705-708.
61. Vieregge, P., B. Heinzow, G. Korf, H. M. Teichert, P. Schleifenbaum, and H. U. Mosinger. 1995. Long term exposure to manganese in rural well water has no neurological effects. Can. J. Neurol. Sci. 22:286-289.
62. Witholt, R., R. H. Gwiazda, and D. R. Smith. 2000. The neurobehavioral effects of subchronic manganese exposure in the presence and absence of pre-parkinsonism. Neurotoxicol. Teratol. 22:851-861.
63. Yamada, M., S. Ohno, I. Okayasu, R. Okeda, S. Hatakeyama, H. Watanabe, K. Ushio, and H. Tsukagoshi. 1986. Chronic manganese poisoning: A neuropathological study with determination of manganese distribution in the brain. Acta. Neuropathol. (Berl.) 70:273-278.
64. Zayed, J., S. Ducic, G. Campanella, J. C. Panisset, P. Andre, H. Masson, and M. Roy. 1990. Environmental factors in the etiology of Parkinson's disease. Can. J. Neurol. Sci. 17:286-291.